RxDoctor Payments Data

Martin Hannon, MD

Family Medicine · Rogers, ARNPI 1124029624

Payments from drug & device makers

$7,513in general payments, 2019–2025

Across 475 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$774
  • Novo Nordisk$650
  • Amgen$568
  • Corium, LLC$544
  • Pfizer$507
  • plus $3K from 40 others

What the payments were for

  • Food & beverage$7,503100%
  • Education$100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,513 in reported general payments places this provider in the 90th percentile of 1,347 family medicine providers in Arkansas.

See all family medicine providers in Arkansas

Medicare billing

Part B allowed, 2024
$99,783
Medicare patients
220
Services billed
3,658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban46$43,709
MounjaroTirzepatide39$42,937
OzempicSemaglutide25$27,531
NucyntaTapentadol Hcl13$18,139
XareltoRivaroxaban11$13,310
Tresiba Flextouch U-200Insulin Degludec16$9,204
Rosuvastatin Calcium250$3,490
Wixela InhubFluticasone Propion/Salmeterol13$2,543
Atorvastatin Calcium244$2,079
SynthroidLevothyroxine Sodium25$2,020
Fluoxetine Hcl37$1,464
Metoprolol Succinate90$1,376
Tamsulosin Hcl51$1,354
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen38$1,236
Leflunomide11$1,196

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$507$43,70946 claims
Lilly USA, LLCMounjaro$774$42,93739 claims
Novo NordiskOzempic$650$27,53125 claims
Collegium Pharmaceutical, Inc.Nucynta$69$18,13913 claims
Johnson & JohnsonXarelto$120$13,31011 claims
AbbVieSynthroid$1,441$2,02025 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,347 family medicine providers in Arkansas.

Other family medicine in Rogers

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →